Synlogic, Inc.
General ticker "SYBX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.9M (TTM average)
Synlogic, Inc. follows the US Stock Market performance with the rate: 52.3%.
Estimated limits based on current volatility of 4.2%: low 1.24$, high 1.36$
Factors to consider:
- Total employees count: 1 as of 2024
- Top business risk factors: Dependency on SYNB1934, Strategic risks and growth management, Potential dissolution or bankruptcy, Insufficient funding, History of losses
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.87$, 2.85$]
- 2025-12-31 to 2026-12-31 estimated range: [0.68$, 2.27$]
Financial Metrics affecting the SYBX estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -186.89 <= 0.33
- Positive: Shareholder equity ratio, % of 64.31 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 149.59 > -0.66
- Negative: negative Industry operating cash flow (median)
Short-term SYBX quotes
Long-term SYBX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.18MM | $3.37MM | $0.01MM |
| Operating Expenses | $68.60MM | $58.53MM | $40.96MM |
| Operating Income | $-67.42MM | $-55.16MM | $-40.95MM |
| Non-Operating Income | $1.27MM | $-6.10MM | $17.60MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $52.04MM | $43.97MM | $9.15MM |
| Income(Loss) | $-66.15MM | $-61.26MM | $-23.35MM |
| Taxes | $0.00MM | $0.01MM | $0.01MM |
| Profit(Loss)* | $-66.15MM | $-57.28MM | $-23.36MM |
| Stockholders Equity | $82.61MM | $42.66MM | $12.75MM |
| Assets | $110.86MM | $75.55MM | $19.83MM |
| Operating Cash Flow | $-56.89MM | $-51.61MM | $-31.66MM |
| Capital expenditure | $0.73MM | $0.21MM | $0.01MM |
| Investing Cash Flow | $58.35MM | $38.77MM | $25.34MM |
| Financing Cash Flow | $-2.04MM | $20.94MM | $0.17MM |
| Earnings Per Share** | $-13.83 | $-8.81 | $-1.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.